As such, the loss of muscle mass reduces the quantity of the primary target for insulin, favoring glucose intolerance and gluconeogenesis, which are key to the pathogenesis of NAFLD. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.